PL4194437T3 - Związek trisiarczkowy - Google Patents

Związek trisiarczkowy

Info

Publication number
PL4194437T3
PL4194437T3 PL21861478.2T PL21861478T PL4194437T3 PL 4194437 T3 PL4194437 T3 PL 4194437T3 PL 21861478 T PL21861478 T PL 21861478T PL 4194437 T3 PL4194437 T3 PL 4194437T3
Authority
PL
Poland
Prior art keywords
trisulfide compound
trisulfide
compound
Prior art date
Application number
PL21861478.2T
Other languages
English (en)
Polish (pl)
Inventor
Shoichiro TOMONAGA
Takahiro Isobe
Etsuo Ohshima
Original Assignee
Kyowa Pharma Chemical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Pharma Chemical Co., Ltd. filed Critical Kyowa Pharma Chemical Co., Ltd.
Publication of PL4194437T3 publication Critical patent/PL4194437T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/40—Y being a hydrogen or a carbon atom
    • C07C323/41—Y being a hydrogen or an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C321/00—Thiols, sulfides, hydropolysulfides or polysulfides
    • C07C321/12—Sulfides, hydropolysulfides, or polysulfides having thio groups bound to acyclic carbon atoms
    • C07C321/14—Sulfides, hydropolysulfides, or polysulfides having thio groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL21861478.2T 2020-08-27 2021-08-23 Związek trisiarczkowy PL4194437T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020143639 2020-08-27
PCT/JP2021/030755 WO2022045052A1 (ja) 2020-08-27 2021-08-23 トリスルフィド化合物

Publications (1)

Publication Number Publication Date
PL4194437T3 true PL4194437T3 (pl) 2026-02-02

Family

ID=80353266

Family Applications (1)

Application Number Title Priority Date Filing Date
PL21861478.2T PL4194437T3 (pl) 2020-08-27 2021-08-23 Związek trisiarczkowy

Country Status (7)

Country Link
US (1) US12534432B2 (cg-RX-API-DMAC7.html)
EP (1) EP4194437B1 (cg-RX-API-DMAC7.html)
JP (1) JP7650279B2 (cg-RX-API-DMAC7.html)
CN (1) CN115943140B (cg-RX-API-DMAC7.html)
ES (1) ES3054285T3 (cg-RX-API-DMAC7.html)
PL (1) PL4194437T3 (cg-RX-API-DMAC7.html)
WO (1) WO2022045052A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230009425A (ko) 2020-05-12 2023-01-17 더 제너럴 하스피탈 코포레이션 신경보호에서의 글루타티온 트리술피드 (gsssg)
CN117320709A (zh) 2021-07-08 2023-12-29 协和医药化工股份有限公司 帕金森病的预防或治疗药
US20260191823A1 (en) 2022-11-21 2026-07-09 Kyowa Hakko Bio Co., Ltd. Prophylactic or therapeutic agent for acute kidney injury induced by anticancer agent
WO2024143400A1 (ja) 2022-12-27 2024-07-04 協和ファーマケミカル株式会社 トリスルフィド化合物
WO2025070464A1 (ja) 2023-09-28 2025-04-03 協和ファーマケミカル株式会社 トリスルフィド化合物を含有する医薬組成物
WO2026058944A1 (ja) * 2024-09-13 2026-03-19 協和ファーマケミカル株式会社 非対称型のトリスルフィド化合物
WO2026127049A1 (ja) * 2024-12-11 2026-06-18 キリンホールディングス株式会社 老化細胞除去用組成物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS532931B2 (cg-RX-API-DMAC7.html) 1973-12-05 1978-02-01
JPS5819673B2 (ja) * 1976-08-26 1983-04-19 相互薬工業株式会社 パンテチンの製造方法
JP2928414B2 (ja) 1991-09-20 1999-08-03 ポーラ化成工業株式会社 皮膚外用剤
SE9402253D0 (sv) * 1994-06-27 1994-06-27 Pharmacia Ab Process
CN107652264A (zh) 2017-09-25 2018-02-02 苏州华诺医药有限公司 硫辛酸杂质a的制备方法
JP2022074166A (ja) * 2019-01-30 2022-05-18 協和発酵バイオ株式会社 ポリスルフィド化合物を含有する組成物
JP2022166333A (ja) * 2019-09-18 2022-11-02 国立大学法人 熊本大学 活性イオウ分子種生体内濃度上昇剤

Also Published As

Publication number Publication date
ES3054285T3 (en) 2026-02-02
CN115943140A (zh) 2023-04-07
EP4194437A1 (en) 2023-06-14
EP4194437A4 (en) 2024-10-02
EP4194437B1 (en) 2025-11-12
EP4194437C0 (en) 2025-11-12
US20230357141A1 (en) 2023-11-09
JPWO2022045052A1 (cg-RX-API-DMAC7.html) 2022-03-03
US12534432B2 (en) 2026-01-27
CN115943140B (zh) 2024-10-01
WO2022045052A1 (ja) 2022-03-03
JP7650279B2 (ja) 2025-03-24

Similar Documents

Publication Publication Date Title
GB202019810D0 (en) Compound
IL304845A (en) Pyrimidopyran compounds
EP4452937A4 (en) CONNECTIONS
EP4194437A4 (en) TRISULFIDE COMPOUND
GB202216325D0 (en) Compound
GB202302314D0 (en) Compound
GB202001564D0 (en) Compounds
GB202301239D0 (en) Compound
GB202217858D0 (en) Compound
GB202009074D0 (en) Compound
EP3981609A4 (en) Trisulfide compound
GB202208329D0 (en) Compound
GB202204673D0 (en) Compound
GB202117834D0 (en) Compound
GB202117836D0 (en) Compound
GB202018245D0 (en) Compound
GB202011787D0 (en) Compound
GB202010626D0 (en) Compound
GB202318958D0 (en) Compound
GB202304745D0 (en) Compound
GB202304355D0 (en) Compound
GB202302315D0 (en) Compound
GB202217856D0 (en) Compound
GB202217854D0 (en) Compound
GB202217823D0 (en) Compound